DaVita Continues International Expansion Efforts With German Acquisition
November 09 2011 - 2:01AM
Business Wire
DaVita Inc. (NYSE: DVA), a leading provider of kidney care
services that is committed to improving the quality of life for
those diagnosed with chronic kidney disease (CKD), today announced
that its wholly owned European subsidiary, DV Care GmbH, has
acquired ExtraCorp AG, a German company that owns two dialysis
centers and manages two additional dialysis centers in Germany.
This transaction represents DaVita’s initial entry on the European
continent and another step in DaVita’s global expansion
strategy.
As a result of the acquisition, DaVita’s European subsidiary now
owns and operates two dialysis centers located in Salzgitter and
Seesen and manages two dialysis centers located in Dresden and
Freital. Each centerwill provide a range of dialysis services in
each center, primarily focused on in-center hemodialysis.
“DaVita and DV Care are committed to continuing the same
high-level of care to end-stage renal disease patients in Germany.
Additionally, these four clinics are an ideal platform for our
European expansion efforts,” said Bjorn Englund, DaVita’s managing
director for Europe. “ExtraCorp has paved the way for us by
delivering outstanding care for its patients at these facilities,
and we look forward to building on this momentum.”
In July of this year DaVita announced the appointment of Englund
as the head of European operations and Atul Mathur as the leader of
Asia-Pacific operations, but its international expansion efforts
began more than a year prior. DaVita executives have been in every
major country in Europe and Asia evaluating markets and identifying
suitable opportunities for partnership and acquisition.
A key advantage for DaVita is the strength of its reputation
overseas. Providers are well aware of DaVita’s leadership in the
area of clinical outcomes, as well as its teammate training and
development expertise. This reputational awareness has opened doors
that previously had been closed to many other American
companies.
Outside of the United States, DaVita currently is providing
dialysis services in Singapore and Bangalore, India, and has an
agreement to develop and operate dialysis clinics in Malaysia.
“The time is right for DaVita to extend to Europe and Asia,”
said DaVita Chairman and CEO Kent Thiry. “Our patient-centric care
model is being well received on both continents.”
DaVita is a registered U.S. trademark of DaVita Inc. All other
trademarks are the property of their respective owners.
About DaVita
DaVita Inc., a Fortune 500® company, is a leading provider of
kidney care in the United States, delivering dialysis services to
patients with chronic kidney failure and end stage renal disease.
DaVita strives to improve patients’ quality of life by innovating
clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services.
As of Sept. 30, 2011, DaVita operated or provided administrative
services at 1,777 dialysis facilities, serving approximately
138,000 patients. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the
world. The company’s leadership development initiatives and social
responsibility efforts have been recognized by Fortune, Modern
Healthcare, Newsweek and WorldBlu. For more information, please
visit www.davita.com.
DaVita (NYSE:DVA)
Historical Stock Chart
From Sep 2024 to Oct 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Oct 2023 to Oct 2024